AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 291: H2630-H2635, 2006. First published August 18, 2006; doi:10.1152/ajpheart.00030.2006
0363-6135/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/6/H2630    most recent
00030.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marques, K. M. J.
Right arrow Articles by Visser, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marques, K. M. J.
Right arrow Articles by Visser, F. C.

TRANSLATIONAL PHYSIOLOGY

The diastolic flow velocity-pressure gradient relation and dpv50 to assess the hemodynamic significance of coronary stenoses

Koen M. J. Marques,1 Machiel J. van Eenige,1 Hugo J. Spruijt,1 Nico Westerhof,2 Jos Twisk,3 Cees A. Visser,1 and Frans C. Visser1

1Department of Cardiology; and 2Department of Physiology, Institute for Cardiovascular Research-Vrije Universiteit; and 3Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands

Submitted 6 January 2006 ; accepted in final form 11 August 2006


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
To evaluate the hemodynamic impact of coronary stenoses, the fractional (FFR) or coronary flow velocity reserve (CFVR) usually is measured. The combined measurement of instantaneous flow velocity and pressure gradient (v-dp relation) is rarely used in humans. We derived from the v-dp relation a new index, dpv50 (pressure gradient at flow velocity of 50 cm/s), and compared the diagnostic performance of dpv50, CFVR, and FFR. Before coronary angiography was performed, patients underwent noninvasive stress testing. In all coronary vessels with an intermediate or severe stenosis, the flow velocity, aortic, and distal coronary pressure were measured simultaneously with a Doppler and pressure guidewire after induction of hyperemia. After regression analysis of all middiastolic flow velocity and pressure gradient data, the dpv50 was calculated. With the use of the results of noninvasive stress testing, the dpv50 cutoff value was established at 22.4 mmHg. In 77 patients, 124 coronary vessels with a mean 39% (SD 19) diameter stenosis were analyzed. In 43 stenoses, ischemia was detected. We found a sensitivity, specificity, and accuracy of 56%, 86%, and 76% for CFVR; 77%, 99%, and 91% for FFR; and 95%, 95%, and 95% for dpv50. To establish that dpv50 is not dependent on maximal hyperemia, dpv50 was recalculated after omission of the highest quartile of flow velocity data, showing a difference of 3%. We found that dpv50 provided the highest sensitivity and accuracy compared with FFR and CFVR in the assessment of coronary stenoses. In contrast to CFVR and FFR, assessment of dpv50 is not dependent on maximal hyperemia.

coronary disease; physiology; catheterization; coronary blood flow


THE FRACTIONAL FLOW RESERVE (FFR) and coronary flow velocity reserve (CFVR) are indexes used during catheterization to assess the hemodynamic effect of a coronary stenosis. The FFR is considered to be a specific index of the epicardial stenosis severity and is defined as the ratio of mean distal (Pd) to proximal (Pprox) coronary pressure at maximal hyperemia (22). The CFVR is the ratio of mean maximal hyperemic to baseline coronary flow velocity and is measured with a Doppler guidewire. The CFVR accounts both for the epicardial and microvascular resistance but does not allow discrimination between these two (5). A good agreement with noninvasive stress tests has been shown for these indexes at cutoff values varying between 1.7 and 2.0 for CFVR and 0.75 for FFR (1, 2, 18, 20, 25).

The combination of both flow velocity and pressure measurements and, more specifically, the diastolic flow velocity-pressure gradient (v-dp) relation gives a comprehensive description of the coronary stenosis severity as has been shown in animal experiments by Gould (7). Recently, we reported on the feasibility and reproducibility of the v-dp relation in humans and found distinct v-dp relations in normal arteries versus intermediate and severe coronary stenoses (16).

We propose a new index, the dpv50, which is derived from the v-dp relation. dpv50 is the instantaneous pressure gradient at a middiastolic coronary flow velocity of 50 cm/s.

The aim of the present study is to compare the diagnostic performance of the dpv50 with the CFVR and FFR in the assessment of the coronary stenosis severity.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Patients. The study population consisted of patients with stable angina pectoris (Canadian Cardiovascular Society class I through III) scheduled to undergo coronary angiography. Before coronary angiography, patients underwent noninvasive ischemia detection either by dobutamine stress echocardiography or by stress technetium-99m sestamibi single photon emission computed tomography (SPECT). Furthermore, a mild to severe stenosis in the proximal part of at least one major coronary artery had to be found at coronary angiography. Exclusion criteria were previous coronary artery bypass grafting, multiple consecutive stenoses in a coronary artery, a very tight stenosis prohibiting simultaneous passage of a Doppler and pressure wire, aneurysmatic morphology, or coronary occlusion. Anti-ischemic medication was continued during catheterization as clinically indicated. The study was approved by the institutional review and ethical committee, and the procedures were in accordance with institutional guidelines. Written informed consent was obtained from all patients.

Myocardial perfusion scintigraphy. SPECT was performed according to a 2-day stress/rest protocol. Exercise or adenosine was used for the stress images. Technetium-99m-labeled sestamibi was injected at maximal exercise or after intravenous infusion of adenosine (0.14 mg·kg–1·min–1). SPECT was performed by using a two-headed gamma camera equipped with low-energy high-resolution collimators. Acquisition was performed using a 360-degree circular orbit. The scintigraphic images were analyzed using a 13-segment model (24). Stress and rest segments were semiquantitatively scored as normal (grade 0) or having a mild, moderate, or severe (grade 3) perfusion defect. Perfusion defects were allocated to the territory of a coronary artery. Defects located in the anterior and anteroseptal region were allocated to the left anterior descending coronary artery (LAD); defects in the posterolateral wall were allocated to the left circumflex coronary artery (LCx) and inferior and basal inferoseptal defects were allocated to the right coronary artery (RCA). Apical defects were considered to be located in the LAD region unless the defect extended to the posterolateral (LCx) or inferior (RCA) wall. Reversible perfusion defects were present when the rest perfusion score improved one grade or more and were considered as positive for the presence of ischemia. Segments with irreversible perfusion defects or normal perfusion were considered negative for the presence of ischemia. The technetium-99m-methoxyisobutylisonitrile (MIBI) scintigrams were scored by two experienced cardiologists; in case of disagreement, a majority decision was achieved by a third cardiologist.

Dobutamine stress echocardiography. An intravenous infusion of dobutamine was started at a rate of 10 µg·kg–1·min–1 and was increased by 10 µg·kg–1·min–1 every 3 min until either wall motion abnormalities were observed or a maximal rate of 40 µg·kg–1·min–1 was reached. In patients who did not reach 90% of their age-adjusted maximal heart rate and who had no objective signs of ischemia, 0.25 mg of atropine was given every minute up to a maximum of 1.0 mg while the dobutamine infusion was continued. End points for stopping the infusion were the same as mentioned in the guidelines (23). Two-dimensional echocardiography was performed obtaining parasternal long- and short-axis views and apical four- and two-chamber views. Imaging was performed throughout the study and during recovery until resolution of new wall motion abnormalities. On-line digital images in quadscreen format were analyzed for the presence, extent, severity, and location of segmental wall motion abnormalities. Myocardial contractile function was graded as normal, hypokinetic, akinetic, or dyskinetic in each segment. An echocardiographic stress test was considered positive when new or worsening stress-induced wall motion abnormalities were observed. The standard algorithm was used to assign ventricular segments to coronary territories: LAD (basal and midanteroseptal segments; basal, mid, and apical anterior segments; mid and apical septal and apical lateral segments); LCx (basal and midlateral segments; basal and midposterior segments); and RCA (basal, mid, and apical inferior segments and basal septal segments) (6). The dobutamine stress echocardiograms were scored by two experienced cardiologists; in case of disagreement, a majority decision was achieved by a third cardiologist.

Cardiac catheterization procedure. All patients received 5,000 IU heparin at the beginning of the procedure. After intracoronary administration of 0.2 mg nitroglycerine, coronary angiography of the left and right coronary artery was performed according to standard procedures. At least two, preferably orthogonal, views were obtained displaying each coronary lesion with minimal foreshortening and no vessel overlap. Quantitative coronary angiography (QCA) was performed off-line using the CAAS II system (CAAS System; Pie Medical Data, Maastricht, The Netherlands). Percentage diameter stenosis and minimal lumen diameter were measured in a standard manner.

FFR, CFVR, and simultaneous flow velocity and pressure measurements. First, the sensor of the pressure wire (Wavewire, Volcano Therapeutics or Radi pressure wire, Radi Medical Systems, Uppsala, Sweden) was advanced close to the tip of the guiding catheter. If a pressure difference was found, the measurement of the pressure wire was electronically adjusted to obtain equalization of pressures. The pressure wire was then advanced distal to the coronary stenosis. The FFR was calculated as the ratio of Pd and Pprox at maximal hyperemia, induced by intracoronary administration of 40 µg adenosine. Subsequently, the Doppler guide wire (Flowire, Volcano Therapeutics) was advanced distal to the stenosis with the Doppler crystal near the sensor of the pressure wire. The Doppler wire was manipulated until an optimal and stable flow velocity signal was obtained. Hyperemia was induced again. Finally, the pressure wire was withdrawn and the CFVR was measured with the Doppler wire as the ratio of mean maximal hyperemic to baseline flow velocity, averaged over two heartbeats.

Assessment of the v-dp relation and dpv50. The pressure measured at the tip of the guiding catheter (aortic pressure), the distal coronary pressure measured by the pressure wire, the instantaneous coronary flow velocity, and the ECG were recorded on a data acquisition unit (Cardiodynamics, Zoetermeer, The Netherlands) connected to a personal computer. Data acquisition (sample frequency 100 Hz) was started before administration of adenosine to disappearance of the hyperemic response (Fig. 1).


Figure 1
View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1. Simultaneous, instantaneous, and mean aortic, distal coronary pressure, and flow velocity recordings before and after intracoronary administration of adenosine (indicated by downward arrow). During a fourfold increase in the mean coronary flow velocity, a mean pressure gradient of 13 mmHg is recorded. For each cardiac cycle after adenosine administration, the middiastolic time window is indicated.

 
The v-dp relation and dpv50 were determined after the following three steps. First, the instantaneous flow velocity values from middiastole to atrial activation and from peak hyperemia to return of baseline condition (on average 20 to 30 cardiac cycles) were plotted against the instantaneous pressure gradient data (aortic minus distal coronary pressure). Second, the v-dp relation was calculated; all data were fitted using a quadratic equation: {Delta}p = 0 + kv + Sv2, where {Delta}p is the pressure gradient (mmHg), v is the coronary flow velocity (cm/s), k is (mmHg·s/cm) the coefficient of pressure loss due to viscous friction, and S (mmHg·s2/cm2) is the coefficient of pressure loss due to flow separation or localized turbulence (26). The k and S coefficients were determined by using the least squares curve-fitting algorithm in the SPSS 9.0 for Windows software package (SPSS, Arlington, VA). In the search for the single instantaneous flow velocity value yielding the highest diagnostic accuracy for all patients and all measurements, we assessed the flow velocities from 10 to 150 cm/s, with incremental steps of 10 cm/s. The highest accuracy was found at a flow velocity of 50 cm/s. Third, based on the k and S coefficients, the dpv50 was calculated. An example is given in Fig. 2.


Figure 2
View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2. A: flow velocity-pressure gradient relation of coronary stenoses A and B (v-dp). For both coronary arteries, all middiastolic data are shown of all cardiac cycles after administration of adenosine. B: regression line, representing the v-dp relation for both stenoses, is displayed. The pressure gradient at a flow velocity of 50 cm/s (dpv50) of stenosis A is 56 mmHg and of stenosis B is 9 mmHg.

 
Diagnostic performance of FFR, CFVR, and dpv50. With the use of the results of the noninvasive stress tests (absence or presence of ischemia during myocardial perfusion scintigraphy or dobutamine stress echocardiography) and ROC analysis, the cutoff value for the dpv50 to discriminate hemodynamic significant and insignificant stenoses was established at 22.4 mmHg. To assess and compare the diagnostic performance of the three indexes, the sensitivity, specificity, and accuracy were determined based on the results of the noninvasive stress tests. For FFR and CFVR the generally recommended cutoff values (FFR 0.75 and CFVR 2.0) were used. We also determined the cutoff values for FFR and CFVR based on this study population.

dpv50 and submaximal hyperemia. To investigate the influence of submaximal hyperemia on the assessment of the dpv50, the following procedure was undertaken. As described in the section on the assessment of the dpv50, all middiastolic flow velocity and corresponding pressure gradient data were plotted. We determined the range of instantaneous flow velocity values for each individual measurement, with the lowest flow velocity value representing 0% and the highest value representing 100% of the range. Then, all data with a flow velocity higher than 75% of the maximal flow velocity were disregarded. The dpv50 was again determined after regression analysis of the remaining data.

Statistical analysis. Continuous variables are presented as mean value (SD). Sensitivity was defined as the number of true positive tests divided by the total number of myocardial territories with ischemia by noninvasive stress testing. Specificity was defined as the number of true negative tests divided by the total number of myocardial territories without ischemia by noninvasive stress testing. Accuracy was defined as the total number of true positive and true negative tests divided by the total number of myocardial territories. The McNemar test was used to compare the sensitivity, specificity, and accuracy of FFR, CFVR, and dpv50. A value of P < 0.05 was considered statistically significant.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Patients characteristics. The study included 77 patients [51 male, 26 female, mean age 60 yr (SD 10)]. Patients demographics and medication are given in Table 1. Four patients had chronic atrial fibrillation. A history of myocardial infarction was present in 44% of patients. Hypertension was present in 40% of patients, diabetes mellitus in 29%, smoking in 45%, and hypercholesterolemia in 52%.


View this table:
[in this window]
[in a new window]
 
Table 1. Patient demographics

 
Results of noninvasive stress testing, quantitative coronary angiographic, and hemodynamic data. Successful measurements were performed in 124 coronary vessels. In 37 patients 1 stenosis, in 33 patients a stenosis in 2 coronary vessels and in 7 patients stenoses in 3 coronary vessels were assessed. Measurements were performed 64 times in the LAD, 39 times in the LCx, and 21 times in the RCA. In 20 patients a stenosis in an infarct-related artery was analyzed. Dobutamine stress echocardiography was performed in 28 (36%) patients. New wall motion abnormalities during dobutamine infusion were found 15 times in the LAD perfusion territory, once in the LCx, and three times in the RCA perfusion territory. In these patients, 41 (24 LAD, 11 LCx, and 6 RCA) coronary arteries were analyzed. MIBI scintigraphy was performed in 49 (64%) patients. Reversible perfusion defects were found 18 times in the LAD perfusion territory, 2 times in the LCx, and 4 times in the RCA territory. In these patients, 83 (40 LAD, 28 LCx, and 15 RCA) coronary arteries were evaluated. When compared with patients who underwent stress echocardiography, diabetes mellitus was significantly more present in patients who underwent MIBI scintigraphy; other patient characteristics did not differ between the two groups (data not shown).

The quantitative coronary angiographic and hemodynamic data are displayed in Table 2. Results are given for all measurements; furthermore, a distinction is made between stenoses with corresponding abnormal and normal noninvasive stress tests. The coronary stenoses with abnormal stress tests had a smaller minimal luminal diameter and higher percentage diameter stenosis, a lower FFR and CFVR, and a higher dpv50. All these differences were statistically significant.


View this table:
[in this window]
[in a new window]
 
Table 2. Quantitative coronary angiographic and hemodynamic data

 
Diagnostic performance of dpv50, FFR, and CFVR. As shown in Table 3, the sensitivity of dpv50 (95%) was significantly higher than FFR (77%) and CFVR (56%). The specificity of dpv50 (95%) was comparable to FFR (99%). The accuracy of dpv50 (95%) and FFR (91%) were significantly higher than CFVR (76%). In this study population the best cutoff value for CFVR and FFR was found at 1.9 and 0.75. For a CFVR of 1.9, the sensitivity, specificity, and accuracy, respectively, were 53%, 91%, and 78%.


View this table:
[in this window]
[in a new window]
 
Table 3. Diagnostic performance of dpv50, FFR, and CFVR

 
As described in METHODS, we also assessed the dpv50 after omitting the upper quartile highest instantaneous flow velocity data. We found a 3% difference between the dpv50 based on all data compared with the dpv50 based on the submaximal measurements. This resulted in one additional false-positive result, decreasing the specificity of the dpv50 from 95% to 94%.

The relation between FFR or CFVR and dpv50 for all measurements is graphically represented in Fig. 3, A and B. The cutoff values for the three indexes are displayed. The data in the lower right and upper left quadrant represent concordant data. In the upper right quadrant of Fig. 3A, discordant measurements (normal FFR and abnormal dpv50) can be found; there were no measurements with an abnormal FFR and normal dpv50 (lower left quadrant). Overall, concordance between dpv50 and FFR was found in 90% of all measurements. From Fig. 3B, it can be appreciated there were more discordant results between CFVR and dpv50 (upper right and lower left quadrant). For the dpv50 and CFVR, concordant results were found in 76% of all measurements.


Figure 3
View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3. A: scatterplot of fractional flow reserve (FFR) and dpv50 data together with the cutoff values. B: scatterplot of coronary flow velocity reserve (CFVR) and dpv50 data together with the cutoff values.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the present study we compared the diagnostic performance of two commonly used invasive indexes, the CFVR and FFR, with a new index, the dpv50, to detect hemodynamic significant coronary stenoses. We found that the dpv50 yielded the highest accuracy. Compared with the FFR, the dpv50 had a significantly higher sensitivity and a similar specificity and accuracy. Furthermore, the dpv50 had a significantly higher sensitivity and accuracy compared with the CFVR. We also demonstrated that maximum hyperemia is not required to reliably assess the dpv50.

Diastolic v-dp and dpv50 to assess the hemodynamic effect of coronary stenoses. Fluid dynamics of coronary artery stenoses are complex (17). The pioneering work of Gould et al. (79) and Young et al. (27) has demonstrated that the relation between pressure gradient and flow velocity in stenoses can be described by {Delta}P = 0 + kv + Sv2. We have previously shown the feasibility to measure the diastolic coronary flow velocity-pressure gradient relation in humans in a reproducible way (16).

To compare the v-dp relation of a stenosis with the FFR or CFVR, it has to be described by a single index. For this purpose the use of the k and S coefficients, which are both required to adequately describe the nonlinear v-dp relation, is not adequate. Therefore, we defined a new index, which is directly derived from the v-dp relation. In the search for the single instantaneous flow velocity value yielding the highest diagnostic accuracy for all patients and all measurements, we assessed the flow velocities from 10 to 150 cm/s, with incremental steps of 10 cm/s. From 30 to 80 cm/s, we found an identical sensitivity of 95%. The specificity ranged from 93% to 95% for the flow velocities from 30 to 60 cm/s. This indicates that within the flow velocity range of 30–60 cm/s, the corresponding instantaneous pressure gradient most reliably characterizes the hemodynamic significance of a stenosis. Within this range, the highest accuracy was found at a flow velocity of 50 cm/s; therefore this value was chosen to use in the present study.

The dpv50 of a coronary stenosis is calculated after regression analysis by using the k and S coefficients. This has three advantages. First, as can be seen in Fig. 2, we found scattering of the data due to noise in the flow velocity (despite a sharply defined flow velocity contour) and pressure data. With the use of all data instead of the average data only with a flow velocity of 50 cm/s, a more reliable assessment of the dpv50 is obtained. Second, in 43 of 124 measurements, a peak instantaneous middiastolic coronary flow velocity lower than 50 cm/s was recorded; 13 of these stenoses did not cause ischemia. In these measurements, the dpv50 could only be assessed after regression analysis and extrapolation. Therefore, in most hemodynamic insignificant stenoses and in some hemodynamic significant stenoses, the dpv50 is a physiological measure. Third, it can be postulated that missing the data at the highest flow velocities will not dramatically alter the course of the regression line and that maximal hyperemia thus is not a prerequisite to reliably assess the dpv50. To test the latter, we omitted for each stenosis the data in the upper quartile of the flow velocities and then reassessed the dpv50. A difference of 3% was found between the dpv50 based on the complete and incomplete data, resulting in one measurement to be reclassified from true negative to false positive. In contrast, assessment of CFVR and FFR by definition requires achievement of maximal hyperemia. In this study, we always gave 40 µg adenosine ic; it has been shown that this dose evokes an equipotent hyperemic response as intravenous adenosine (4). In the literature it has been suggested that for technical and pharmacokinetic reasons, intracoronary administration of adenosine may induce only submaximal hyperemia, resulting in underestimation of a coronary stenosis when FFR and overestimation when CFVR is used (4, 14, 19, 21). Furthermore, it remains uncertain whether adenosine can elicit maximal hyperemia. It has been shown that the addition of {alpha}1- and {alpha}2-adrenergic blocking agents to adenosine induces a stronger hyperemic stimulus after PCI, in patients with coronary atherosclerosis and in normal humans (1012, 15). Coronary occlusion also can induce a stronger hyperemic response than adenosine (13).

Spatial resolution of dpv50. In this study we took care to determine the dpv50 distal to the most distal stenosis visible at angiography. However, flow velocity and coronary pressure can be measured simultaneously at any location in a coronary artery. If flow and pressure data are obtained at the same spot, the dpv50 gives information on the epicardial resistance from the coronary ostium to the location where measurements are obtained. By the virtue not to be dependent on maximal hyperemia, the dpv50 of a coronary segment thus can be assessed irrespective of any additional epicardial or microcirculatory resistance distal to the point of measurement. Therefore, in case of diffuse atherosclerosis or serial epicardial stenoses, by determining the dpv50 at different spots, the location with the largest resistance can be identified.

Study limitations. In six measurements it was not possible to obtain optimal Doppler flow velocity recordings, and in these cases no reliable v-dp relation could be computed. The cutoff value of the dpv50 in this study is derived from measurements with two wires through a coronary stenosis, probably increasing its severity. Very recently, a single 0.014" wire (ComboWire, Volcano Therapeutics, Rancho Cordova, CA) allowing combined flow velocity and pressure measurements has become available for clinical use. The diagnostic performance of the dpv50 was assessed based on the cutoff value established in the same study population; this might lead to a bias toward better test results. To properly determine the accuracy of the dpv50 in the assessment of coronary stenoses, a prospective study is needed to establish the predictive value of this cutoff value. It can be assumed on theoretical grounds that the v-dp relation and dpv50 are independent of hemodynamic conditions (heart rate, aortic pressure, and contractility) (3). This has not been thoroughly evaluated yet. However, in patients with atrial fibrillation we found that the data of each cardiac cycle fitted the same v-dp curve, despite widely varying cardiac cycle lengths and aortic pressure. To further investigate the effect of heart rate and changes of preload on the dpv50, measurements at different pacing rates should be done. Measurements in a poststenotic aneurysmatic part of a coronary artery modify the v-dp relation. Therefore, we always have measured in the distal, normally sized part of the coronary artery. Coronary arteries with a very diffuse, ectatic appearance were excluded from this study. At the present time, computation of the dpv50 has to be done off-line.

In conclusion, we found a very high sensitivity and specificity for the dpv50 in the assessment of the hemodynamic significance of coronary stenoses. In contrast to the CFVR and FFR, calculation of the dpv50 is not critically dependent on the induction of maximal hyperemia.


    ACKNOWLEDGMENTS
 
The authors acknowledge the technical and nursing staff of the cardiac catheterization laboratory for their skilled assistance.


    FOOTNOTES
 

Address for reprint requests and other correspondence: K. M. J. Marques, VU Univ. Medical Center, Dept. of Cardiology, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands (e-mail: km.marques{at}VUmc.nl)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Chamuleau SA, Meuwissen M, Eck-Smit BL, Koch KT, de Jong A, de Winter RJ, Schotborgh CE, Bax M, Verberne HJ, Tijssen JG, and Piek JJ. Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single-photon emission computed tomography in patients with two-vessel coronary artery disease. J Am Coll Cardiol 37: 1316–1322, 2001.[Abstract/Free Full Text]
  2. de Bruyne B, Bartunek J, Sys SU, and Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 92: 39–46, 1995.[Abstract/Free Full Text]
  3. de Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, and Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 94: 1842–1849, 1996.[Abstract/Free Full Text]
  4. de Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, and Heyndrickx GR. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 107: 1877–1883, 2003.[Abstract/Free Full Text]
  5. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, and Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 85: 1899–1911, 1992.[Abstract/Free Full Text]
  6. Feigenbaum H. Echocardiography and coronary artery disease. Int J Card Imaging 9, Suppl 2: 55–67, 1993.
  7. Gould KL. Pressure-flow characteristics of coronary stenoses in unsedated dogs at rest and during coronary vasodilation. Circ Res 43: 242–253, 1978.[Abstract/Free Full Text]
  8. Gould KL and Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34: 48–55, 1974.[CrossRef][Web of Science][Medline]
  9. Gould KL, Lipscomb K, and Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 33: 87–94, 1974.[CrossRef][Web of Science][Medline]
  10. Gregorini L, Fajadet J, Robert G, Cassagneau B, Bernis M, and Marco J. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation 90: 895–907, 1994.[Abstract/Free Full Text]
  11. Gregorini L, Marco J, Farah B, Bernies M, Palombo C, Kozakova M, Bossi IM, Cassagneau B, Fajadet J, di Mario C, Albiero R, Cugno M, Grossi A, and Heusch G. Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 106: 2901–2907, 2002.[Abstract/Free Full Text]
  12. Heusch G, Baumgart D, Camici P, Chilian W, Gregorini L, Hess O, Indolfi C, and Rimoldi O. alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 101: 689–694, 2000.[Abstract/Free Full Text]
  13. Jeremias A, Filardo SD, Whitbourn RJ, Kernoff RS, Yeung AC, Fitzgerald PJ, and Yock PG. Effects of intravenous and intracoronary adenosine 5'-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation 101: 318–323, 2000.[Abstract/Free Full Text]
  14. Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, and Yock PG. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 140: 651–657, 2000.[CrossRef][Web of Science][Medline]
  15. Lorenzoni R, Rosen SD, and Camici PG. Effect of {alpha}1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans. Am J Physiol Heart Circ Physiol 271: H1302–H1306, 1996.[Abstract/Free Full Text]
  16. Marques KM, Spruijt HJ, Boer C, Westerhof N, Visser CA, and Visser FC. The diastolic flow-pressure gradient relation in coronary stenoses in humans. J Am Coll Cardiol 39: 1630–1636, 2002.[Abstract/Free Full Text]
  17. Mates RE, Gupta RL, Bell AC, and Klocke FJ. Fluid dynamics of coronary artery stenosis. Circ Res 42: 152–162, 1978.[Abstract/Free Full Text]
  18. Miller DD, Donohue TJ, Younis LT, Bach RG, Aguirre FV, Wittry MD, Goodgold HM, Chaitman BR, and Kern MJ. Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 89: 2150–2160, 1994.[Abstract/Free Full Text]
  19. Murtagh B, Higano S, Lennon R, Mathew V, Holmes DR Jr, and Lerman A. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. Am Heart J 146: 99–105, 2003.[CrossRef][Web of Science][Medline]
  20. Pijls NH, de Bruyne B, Peels K, Van Der Voort, Bonnier HJ, Bartunek JKJ, and Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334: 1703–1708, 1996.[Abstract/Free Full Text]
  21. Pijls NH, Kern MJ, Yock PG, and de Bruyne B. Practice and potential pitfalls of coronary pressure measurement. Catheter Cardiovasc Interv 49: 1–16, 2000.[CrossRef][Web of Science][Medline]
  22. Pijls NH, Van Gelder B, Van Der Voort PH, Peels K, Bracke FA, Bonnier HJ, and el Gamal MI. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92: 3183–3193, 1995.[Abstract/Free Full Text]
  23. Quinones MA, Douglas PS, Foster E, Gorcsan J III, Lewis JF, Pearlman AS, Rychik J, Salcedo EE, Seward JB, Stevenson JG, Thys DM, Weitz HH, Zoghbi WA, Creager MA, Winters WL Jr, Elnicki M, Hirshfeld JW Jr, Lorell BH, Rodgers GP, Tracy CM, and Weitz HH. American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians–American Society of Internal Medicine Task Force on Clinical Competence. Circulation 107: 1068–1089, 2003.[Free Full Text]
  24. Ritchie J, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ, O'Rourke RA, Parisi AF, and Verani MS. Guidelines for clinical use of cardiac radionuclide imaging. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures, Committee on Radionuclide Imaging, developed in collaboration with the American Society of Nuclear Cardiology. Circulation 91: 1278–1303, 1995.
  25. Tron C, Donohue TJ, Bach RG, Aguirre FV, Caracciolo EA, Wolford TL, Miller DD, and Kern MJ. Comparison of pressure-derived fractional flow reserve with poststenotic coronary flow velocity reserve for prediction of stress myocardial perfusion imaging results. Am Heart J 130: 723–733, 1995.[CrossRef][Web of Science][Medline]
  26. Young DF, Cholvin NR, Kirkeeide RL, and Roth AC. Hemodynamics of arterial stenoses at elevated flow rates. Circ Res 41: 99–107, 1977.[Abstract/Free Full Text]
  27. Young DF, Cholvin NR, and Roth AC. Pressure drop across artificially induced stenoses in the femoral arteries of dogs. Circ Res 36: 735–743, 1975.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. L. Gould
Physiological severity of coronary artery stenosis
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2583 - H2585.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/6/H2630    most recent
00030.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marques, K. M. J.
Right arrow Articles by Visser, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marques, K. M. J.
Right arrow Articles by Visser, F. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.